Single-Agent Pemetrexed or Sequential Pemetrexed/Gemcitabine as Front-Line Treatment of Advanced Non-small Cell Lung Cancer in Elderly Patients or Patients Ineligible for Platinum-Based Chemotherapy: A Multicenter, Randomized, Phase II Trial-Reference-Cited by-同舟云学术

Single-Agent Pemetrexed or Sequential Pemetrexed/Gemcitabine as Front-Line Treatment of Advanced Non-small Cell Lung Cancer in Elderly Patients or Patients Ineligible for Platinum-Based Chemotherapy: A Multicenter, Randomized, Phase II Trial

Published:2007-03 Issue:3 Volume:2 Page:221-229
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Gridelli Cesare,Kaukel Eckhard,Gregorc Vanessa,Migliorino Maria Rita,Müller Thomas R.,Manegold Christian,Favaretto Adolfo,Martoni Andrea,Caffo Orazio,Schmittel Alexander,Rossi Antonio,Russo Francesca,Peterson Patrick,Muñoz María,Reck Martin

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference45 articles.

1. SEER Cancer Statistics Review 1975–2000;Ries,2003

2. Lung cancer in the elderly;Gridelli;Eur J Cancer,1997

3. Participation of patients 65 years of age or older in cancer clinical trials;Lewis;J Clin Oncol,2003

4. Underrepresentation of patients 65 years of age or older in cancer-treatment trials;Hutchins;N Engl J Med,1999

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modern therapies of nonsmall cell lung cancer;Journal of Applied Genetics;2023-09-12

2. Best first-line therapy for people with advanced non-small cell lung cancer, performance status 2 without a targetable mutation or with an unknown mutation status;Cochrane Database of Systematic Reviews;2023-07-07

3. Deciphering the mechanism and binding interactions of Pemetrexed with dsDNA with DNA-targeted chemotherapeutics via spectroscopic, analytical, and simulation studies;Journal of Pharmaceutical and Biomedical Analysis;2022-02

4. CheckMate 171: A phase 2 trial of nivolumab in patients with previously treated advanced squamous non-small cell lung cancer, including ECOG PS 2 and elderly populations;European Journal of Cancer;2020-03

5. Sequence-dependent synergistic cytotoxicity of icotinib and pemetrexed in human lung cancer cell lines in vitro and in vivo;Journal of Experimental & Clinical Cancer Research;2019-04-05